Peter Buhl Hjortrup retweeted
1/9
#AIDICU trial results on haloperidol vs. placebo for the treatment of delirium in ICU patients @NEJM
Amazing work in 16 ICUs 🇩🇰🇫🇮🏴🇮🇹
Funded by
@Innofond
@regionsjaelland
@regionerne
nejm.org/doi/full/10.1056/NE…
Peter Buhl Hjortrup retweeted
The CLASSIC trial result presentation from #CCR22 is now out
criticalcarereviews.com/meet…
➡️Presentation @TineMeyhoff
➡️ Editorial @KathMaitland
➡️ Panel @DavidHarrison80 @Lennie333 @AndersPerner @jon_silversides
Chair Bala Venkatesh
@pbhjortrup @MortenHylander @CRIC_Int_Care
Peter Buhl Hjortrup retweeted
#COVID19 cardiovascular impact in critically ill
➡️pathophysiology behind increased long term risk?
➡️trajectory of US findings?
➡️influence of vaccines/immunomodulatory drugs?
➡️role for prophylaxis?
📖https://nitter.gq/t.co/DjNIjAcxY5
Refers to ECHO-COVID study
📖rdcu.be/cNgIu
Peter Buhl Hjortrup retweeted
One of the most outstanding questions in critical care is whether patients benefit from IV fluid resuscitation in septic shock.
A thread...
(image shutterstock)
1/16
Peter Buhl Hjortrup retweeted
The 532nd Critical Care Reviews Newsletter, bringing you the best critical care research and open access articles from across the medical literature for the week February 14th to 20th, is now out
criticalcarereviews.com/news…
CCR is supported by @MyIntensiveCare
Peter Buhl Hjortrup retweeted
Only 100 to go in #CLASSICtrial. Restricted vs standard IV fluids in adults w. septic shock. Outstanding work from 31 ICUs 🇩🇰🇨🇭🇸🇪🇳🇴🇨🇿🇮🇹🇧🇪🇬🇧
@AndersPerner @TineMeyhoff @MortenHylander @pbhjortrup
Peter Buhl Hjortrup retweeted
The unedited videos of the first 2 days of #eCCR21 are now available on the (temporary...) website.
I'll get the edited versions up as quick as I can
ccrtestsite.com/
True and effective
@leochacon @SineWichmann @ARanberg @AJKDonline @foxtrot_ea @ole_mathiesen @JSchmcker @ICR311 @Area_Critica_ @EduMed_UK
True and effective
@leochacon @SineWichmann @ARanberg @AJKDonline @foxtrot_ea @ole_mathiesen @JSchmcker @ICR311 @Area_Critica_ @EduMed_UK
Peter Buhl Hjortrup retweeted
Just 9 weeks to eCCR21. We start to release the programme this week. Just the 5 major trial results to be hosted, 11 of the best critical care trials of 2020 to be presented by their chief investigators, plus a little more...
All freely live streamed.
#eCCR21
Peter Buhl Hjortrup retweeted
Er du vores næste ph.d. studerende?
Ph.d. studerende søges til Centre of Anaesthesiological Reserach, Anæstesiologisk Afdeling, SUH, Køge via Sundhedsjobs.dk sundhedsjobs.dk/jobopslag/39…
Peter Buhl Hjortrup retweeted
#ICU pts receive vast amounts of IV fluids: choosing right solution/volume to avoid harm challenging. Design/conduction of trials complex, lot of unanswered questions: debates not likely to end soon but each high-quality trial is small step toward solution rdcu.be/b6kQD
Peter Buhl Hjortrup retweeted
Good news in the midst of the pandemic.
The CLASSIC trial is halfway!
Thanks a million to clinical staff, relatives and patients! Trial results will improve outcomes of septic shock.
@AndersPerner @TineMeyhoff @pbhjortrup @MortenHylander @Majkja
Peter Buhl Hjortrup retweeted
Finally a good study on High risk of thrombosis in patients in severe SARS-CoV-2 infection: a multicenter prospective cohort study accepted by @yourICM by @juliehelms available at esicm.org/wp-content/uploads… as preproof
Peter Buhl Hjortrup retweeted
500 patients randomized in the AID-ICU trial and thereby halfway - improving outcomes for #icudelirium! Thanks to all our AID-investigators.
@MusaeusPoulsen
@AndersPerner
@BodilSRasmussen
Peter Buhl Hjortrup retweeted
Now >700 patients included in #classictrial - we're still recruiting and we're almost halfway!
Improving outcomes for #septicshock , including that caused by critically ill patients with #SARSCOV2
@AndersPerner @TineMeyhoff @Majkja @MortenHylander @pbhjortrup
Peter Buhl Hjortrup retweeted
Don't forget you can enjoy free talks on cardiac arrest management from world exports over breakfast
scanfoam.org/bigsick20/
#FOAMed
Peter Buhl Hjortrup retweeted
65 Trial & BIRDS Trial - Don't miss the oppertunity to hear more about these important trials at the SIM meeting in Copenhagen!
Peter Buhl Hjortrup retweeted
Big day for #CLASSICtrial reaching a new milestone: 500 septic shock patients randomised to restrictive IV fluid vs standard-care.
6 active countries 🇩🇰🇸🇪🇨🇿🇳🇴🇮🇹 and more to come!
@AndersPerner @MortenHylander @pbhjortrup @Majkja @TineMeyhoff






















